Filing Flows › Evolus (EOLS) › Q3 2026 › vs Q2 2026
Evolus (EOLS) Q3 2026 vs Q2 2026 (quarter over quarter)
Evolus's revenue fell $6.1M (-7%) from $84.1M in Q2 2026 to $78.0M in Q3 2026. The biggest changes: Product revenue, net −$6.1M (-7%); Service revenue +$7K (+1%).
Evolus, Q3 2026: revenue $78.0M (+13% year over year), operating margin -10.8%, net loss $12.5M, operating cash flow −$1.9M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Product revenue, net | $77.2M | $83.3M | −$6.1M | -7% |
| Service revenue | $741K | $734K | $7K | +1% |
| Revenue | $78.0M | $84.1M | −$6.1M | -7% |
| Net loss | $12.5M | $8.1M | $4.5M | +55% |
| Costs & expenses | $90.5M | $92.3M | −$1.8M | -2% |
| Operating costs | $86.4M | $88.6M | −$2.2M | -3% |
| Interest & other, net | $3.8M | $3.7M | $140K | +4% |
| Income tax | $285K | −$154K | $439K | — |
| Cost of revenue | $27.3M | $26.9M | $362K | +1% |
| Research & development | $2.0M | $1.9M | $76K | +4% |
| SG&A | $52.9M | $57.1M | −$4.1M | -7% |
| Other operating costs | $4.2M | $2.8M | $1.4M | +52% |
| Operating cash sources | $12.5M | $8.1M | $4.5M | +55% |
| Depreciation & amortization | $2.4M | $2.3M | $48K | +2% |
| Share-based compensation | $5.6M | $5.6M | −$19K | -0.3% |
| Working capital & other | $2.6M | −$3.5M | $6.1M | — |
| Cash used in operations | $1.9M | $3.6M | −$1.7M | -46% |
| Net loss absorbed | $12.5M | $8.1M | $4.5M | +55% |
Questions
How much did Evolus's revenue grow quarter over quarter in Q3 2026?
Evolus's revenue fell $6.1M (-7%) from $84.1M in Q2 2026 to $78.0M in Q3 2026.
What drove Evolus's revenue change in Q3 2026?
Product revenue, net −$6.1M (-7%); Service revenue +$7K (+1%).